Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2021 | Areas of unmet need in patients with mastocytosis

Tracy George, MD, The University of Utah, Salt Lake City, UT, talks on areas of unmet need for the diagnosis, classification, and treatment of mastocytosis, including optimizing therapeutic approaches in patients with co-existing hematological malignancies often seen in systemic mastocytosis. In indolent mastocytosis, Prof. George highlights the benefit of avapritinib in patients with KIT mutations and touches on the pediatric population who also represent an area of unmet need. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Disclosures

Tracy George, MD, has served as a consultant for Blueprint Medicines Corporation.